Clinical trials
Weight Loss trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 8 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Certmedica International GmbH | 4 |
| University of Bologna | 3 |
| DiaSorin Inc. | 2 |
| University of Roma La Sapienza | 2 |
| Advice Pharma Group srl | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
| Azienda Ospedaliero Universitaria Maggiore della Carita | 1 |
| Azienda Ospedaliero, Universitaria Pisana | 1 |
| Azienda Ospedaliero-Universitaria Careggi | 1 |
| Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weight Loss | 37 |
| Obesity | 21 |
| Overweight | 13 |
| Anorexia | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Body Weight | 3 |
| Cachexia | 3 |
| Malnutrition | 3 |
| Neoplasms | 3 |
| Abdominal Pain | 2 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.